Please login to the form below

Not currently logged in
Email:
Password:

esketamine

This page shows the latest esketamine news and features for those working in and with pharma, biotech and healthcare.

Daily Brief

Daily Brief

Two Phase III clinical studies of its esketamine nasal spray in patients with treatment-resistant depression, combined with a newly initiated oral antidepressant, produced a clinically meaningful rapid reduction of depressive ... Esketamine received

Latest news

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics